The Financial Times reports that AbbVie is close to acquiring biotechnology company Apogee Therapy for approximately $11 billion. The deal is expected to be announced as early as Monday.

2026-06-19

The Financial Times reports that AbbVie is close to acquiring biotechnology company Apogee Therapy for approximately $11 billion. The deal is expected to be announced as early as Monday.